New concepts in HIV-1 vaccine development

Area of Science:

• Immunology
• Vaccinology
• Virology

Background:

• An effective human immunodeficiency virus type 1 (HIV-1) vaccine is a critical global health need, with millions newly infected annually.
• Previous vaccine trials and animal studies have highlighted specific immune responses that may indicate protection against HIV-1.

Purpose of the Study:

• To review the immunological correlates of protection identified in HIV-1 vaccine research.
• To discuss how these correlates are informing current HIV-1 vaccine development strategies.

Main Methods:

• Review of human vaccine efficacy trials and non-human primate immunization studies.
• Analysis of identified vaccine-induced immunological responses, including antibody and T cell functions.
• Examination of current HIV-1 vaccine development approaches informed by these correlates.

Main Results:

• Key potential correlates of protection include V2-specific, polyfunctional, and broadly neutralizing antibodies.
• Effector memory T cell responses are also identified as important correlates.
• These correlates are guiding the refinement of existing vaccine regimens and the development of novel approaches.

Conclusions:

• Understanding immunological correlates of protection is essential for advancing HIV-1 vaccine design.
• Current strategies leverage these insights, exploring improved regimens, novel vectors, and antibody-based therapies.